Immune Checkpoint Inhibitor Side Effects: Rising Incidence, Stable Mortality & High-Risk Events
The landscape of cancer treatment has been dramatically altered in recent years by the advent of immunotherapy, specifically through the use of immune checkpoint inhibitors (ICIs). These therapies, while offering significant hope for improved prognoses, are not without risk. A recent international study has highlighted the increasing frequency of adverse events (AEs) associated with ICIs, … Read more
